Haleon Plc (HLNCF)
4.375
-0.08
(-1.91%)
USD |
OTCM |
Oct 05, 16:00
Haleon Price : 4.375 for Oct. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 05, 2026 | 4.26 | 4.395 | 4.26 | 4.375 | 19185.00 |
| Oct 02, 2026 | 4.345 | 4.46 | 4.345 | 4.46 | 13583.00 |
| Oct 01, 2026 | 4.395 | 4.40 | 4.395 | 4.40 | 1603.00 |
| Sep 30, 2026 | 4.515 | 4.515 | 4.30 | 4.475 | 8054.00 |
| Sep 29, 2026 | 4.43 | 4.46 | 4.32 | 4.32 | 2194.00 |
| Sep 28, 2026 | 4.38 | 4.524 | 4.37 | 4.524 | 27885.00 |
| Sep 25, 2026 | 4.52 | 4.52 | 4.40 | 4.40 | 53443.00 |
| Sep 24, 2026 | 4.53 | 4.54 | 4.53 | 4.54 | 1542.00 |
| Sep 23, 2026 | 4.575 | 4.64 | 4.36 | 4.64 | 5013.00 |
| Sep 22, 2026 | 4.579 | 4.60 | 4.579 | 4.60 | 400975.0 |
| Sep 21, 2026 | 4.51 | 4.51 | 4.51 | 4.51 | 1645.00 |
| Sep 18, 2026 | 4.51 | 4.51 | 4.51 | 4.51 | 1808.00 |
| Sep 17, 2026 | 4.595 | 4.595 | 4.595 | 4.595 | 0.000 |
| Sep 16, 2026 | 4.595 | 4.595 | 4.58 | 4.595 | 2678.00 |
| Sep 15, 2026 | 4.545 | 4.73 | 4.545 | 4.585 | 8027.00 |
| Sep 14, 2026 | 4.625 | 4.79 | 4.615 | 4.665 | 27233.00 |
| Sep 11, 2026 | 4.535 | 4.535 | 4.535 | 4.535 | 3387.00 |
| Sep 10, 2026 | 4.55 | 4.55 | 4.55 | 4.55 | 12345.00 |
| Sep 09, 2026 | 4.525 | 4.545 | 4.525 | 4.545 | 26618.00 |
| Sep 08, 2026 | 4.575 | 4.76 | 4.575 | 4.615 | 1320.00 |
| Sep 04, 2026 | 4.89 | 4.89 | 4.739 | 4.739 | 852.00 |
| Sep 03, 2026 | 4.935 | 4.935 | 4.935 | 4.935 | 712.00 |
| Sep 02, 2026 | 4.78 | 4.935 | 4.78 | 4.935 | 1237.00 |
| Sep 01, 2026 | 4.875 | 4.875 | 4.875 | 4.875 | 9.000 |
| Aug 31, 2026 | 4.94 | 5.035 | 4.875 | 4.875 | 2297.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AstraZeneca PLC | 158.58 |
| GSK Plc | 46.60 |
| Hikma Pharmaceuticals Plc | 21.10 |
| Allergy Therapeutics Plc | 0.15 |
| Shield Therapeutics Plc | 0.0856 |
Price Related Metrics
| PE Ratio | 18.00 |
| PS Ratio | 2.618 |
| PEG Ratio | 0.284 |
| Price to Free Cash Flow | 14.89 |
| Earnings Yield | 5.56% |
| Market Cap | 38.39B |
| PEGY Ratio | 0.2742 |
| Operating PE Ratio | 11.23 |
| Normalized PE Ratio | 16.35 |